65,437 trials
Healthy
Primary: AUC(0-tz) of Unconjugated Rotigotine — 3.0168; 3.0635 (ng/ mL)*h
Overactive Bladder · Detrusor Overactivity
Primary: Change From Baseline in Bladder Volume at First Detrusor Contraction at 6 Weeks — 44.993; 36.948 mL — p=0.5293
Pulmonary Disease, Chronic Obstructive
Primary: Activities of Daily Living Score After 3 to 4 Weeks Treatment With Spiriva — 1.1 points on a scale
HIV Infections
Primary: Treatment Response at Week 48 — 34.5; 15 percentage of participants — p=0.0001
Parkinson Disease
Primary: Food Effects on Cmax and Cmin of SKF101468 (Ropinirole) and Its Metabolites — 1563.784; 1542.182; 728.404; 725.103 picograms/milliliter (pg/mL)
Atrial Fibrillation · Atrial Flutter
Primary: First Hospitalization for Cardiovascular Reason or Death From Any Cause — 734; 917 participants — p=<0.0001
Nasolabial Folds
Primary: Number Participants With Hypertropic Scarring, Keloid Formation, Hyper- or Hypopigmentation in Patients With Fitzpatrick Skin Types IV, V, and VI Receiving Nasolabial…
Rhinitis, Allergic, Perennial
Primary: Mean Change From Baseline Over the Entire Treatment Period in Daily Reflective Total Nasal Symptom Scores (rTNSS) — -2.45; -3.19 Points on a scale — p=0.004
Bacterial Infection
Primary: Maximum Plasma Concentration (Cmax) of Doxycycline — 2.526; 2.442 ug/mL
Colorectal Cancer
Primary: Tumor Response by Response Evaluation Criteria In Solid Tumors (RECIST) — 1; 2; 3; 15 participants
ERCP · Pancreatic Diseases · Bile Duct Diseases
Primary: The Grades of the Number of Duodenal Contractions — 1.13; 1.17 scores on a scale
Detrusor Hyperreflexia
Primary: Average Catheterization Urine Volume — 95.3; 114.0; 30.0; 52.4 mL
HIV Infections
Primary: Change From Baseline to Week 12 in Fasting Triglycerides — -0.5; -0.1 mmol/L — p=0.034
Attention Deficit Hyperactivity Disorder
Primary: Discontinuations Due to Adverse Events (AE) — 1; 1 participants
Breast Neoplasms
Primary: Time to Reach Maximum Plasma Concentration (Tmax): Sunitinib (SU011248), Sunitinib Metabolite (SU012662), and Total Drug PK Parameters — 6.0; 6.0; 6.0; 6.0 hours